"On a molecular level, our structural studies reveal that interdictors bind in a linkerless heterobifunctional manner to both the rRNA and the nascent peptide chain ... much the way a PROTAC can be modularly designed and constructed"
Steven Cheng
Context-dependent translation inhibition as a novel oncology therapeutic modality https://www.biorxiv.org/content/10.1101/2025.01.09.632223v1
